Neuropathology: Increase in Use of Neuropathology Diagnostics in The Hospitals and Other Surgical Centers will Boost Market at a Strong CAGR of 6% During The Forecast Period 2017-2023

Pune, India, December 2017 /MRFR Press Release/- Market Research Future has a half-cooked research report on the Global Neuropathology Market.

Neuropathology Market Highlights

The increasing number of bone grafting procedures and penetration of orthopaedic speciality hospitals and healthcare insurance are the factors principally driving the global neuropathology market.

More and more people are getting aware about the neuropathology services and the perks of having neuropathology assistance while undergoing surgical procedures. There has been substantial increase in the number of people opting for the neuropathology services. However unstable economic condition of Europe is one of the factors hampering the growth of the neuropathology services to an extent in the European region. Overall, The neuropathology market in European region is on its rise and will continue to grow in the near future.

In addition to the conventional nerve analysis including teasing fiber preparation and electron microscopic examination, our laboratory also provides the evaluation of skin biopsy to detect abnormalities of epidermal nerve fiber density for patients with small fiber neuropathy.

Neuropathology is now one of the widely adopted diagnostic techniques in the North American countries such as the United States and Canada. People are more aware about the process and are opting to undergo these technique. But globally the use of neuropathology is still very limited. Be it the less availability of the skilled personnel or the lack of awareness about the neuropathology techniques and its benefits.

It is estimated that global Neuropathology market is expected to grow at a CAGR 6% during the forecast period of 2017-2023.

Neuropathology Market Regional Analysis

Global Neuropathology consists of regions namely Americas, Europe, Asia Pacific, and the Middle East.

North America dominated the global neuropathology market. There are great opportunities in the neuropathology market in the near future as there has been great development in the diagnostic techniques. Considering the scenario, the existing big companies have optimized their focus in order to cope with the market. Besides this, there are number of third party vendors offering in the neuropathology testing services. As a result, many of the hospitals are opting for the outsourcing of the neuropathology tests to these third party vendors as they have highly skilled staff and well-built infrastructure. Outsourcing these services reduces hospital’s expenses by huge amount. North America has the biggest outsourcing market for the neuropathology diagnostictesting services.

The European market is growing at a steady pace and is anticipated to compete with the American market. As a result of advancement in the diagnostic techniques and development of the neurology and anatomy industry in Europe, the Neuropathologys market has grown significantly in the region.

Asia Pacific is expected to be the fastest growing region in the bone graft substitute market during the forecasted period 2017 to 2023. Currently Asia is having a limited market in neuropathology  as compared to North America. Awareness of  neuropathology  testing is growing worldwide. Asia is one of the fastest growing regions in the neuropathology  market. There has been tremendous rise in the adoption of neuropathology diagnostic testing during surgical procedures. Japan, China and India are among the top countries in Asia where the growth of the neuropathology market is substantial. Government policies, healthcare advancements and development in the infrastructure are some of the key factors driving the growth of the neuropathology  market in the Asian region. If Asian market continues to grow at the current rate, it is estimated to be at par with the European region in a few years.

Segmentation

The Neuropathology is segmented on the basis of diagnosis test, application, and end-users.

On the basis of diagnostic test, the market is segmented into the biopsy, body fluids, peripheral blood smears, histochemical method, immunohistochemical methods, tissue resections, and others 

The Biopsy sub-segment is divided into Epidermal nerve fiber density testing (ENFD), Sural nerve biopsy test, bone-marrow biopsies, lymph-node biopsies and others

On the basis of product, the application market is segmented into cerebral hypoxia and stroke, perinatal disorders, CNS infections, demyelinative diseases, brain tumors, neurodegenerative diseases, inherited metabolic disorders, peripheral neuropathy, and myopathology

On the basis of end-user, the market is segmented into hospitals, clinics, research centers and others.

Key Players

Some of key the players in the Global Neuropathology Market are ARUP Laboratories, Therapath LLC, Abbott Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sakura Finetek USA Inc., Danaher Corporation, Quest Diagnostics Incorporated, Agilent Technologies Inc., and NeoGenomics Laboratories and others.